After finishing my PhD in Biochemistry from the MCB program at the Geisel School of Medicine, I did a postdoctoral fellowship at the University of Washington's Institute for Protein Design in Seattle. Next, I joined the Institute for Protein Innovation in Boston where I was the Head of Protein Design. At the IPI, I led an academic research group that paired computational de novo protein design with high-throughput protein biochemistry and biophysics. We developed a novel drug discovery platform, which we spun out into a biotech company called AI Proteins, where I am the Chief Scientific Officer and Co-founder. I'm also a part-time Lecturer at Boston Children's Hospital and Harvard Medical School.
One thing that's unique and special about Dartmouth is how much the faculty genuinely care about the graduate students. It is an amazingly supportive and encouraging environment, and the training programs are built from the ground up to support student development. I haven't come across a better research community to be a graduate student.
Here's a TED talk that I gave a couple of years ago on the technology that AI Proteins is based on:
https://www.ted.com/talks/christopher_bahl_a_new_type_of_medicine_custom_made_with_tiny_proteins